Liver resection for hepatocellular carcinoma in patients with metabolic syndrome: A multicenter matched analysis with HCV-related HCC

Journal of Hepatology

Volumn 63, Issue 1, 2015, Pages 93-101

  Viganò, Luca ^a,b   Conci, Simone ^c   Cescon, Matteo ^d   Fava, Cristina ^b   Capelli, Paola ^e   D'Errico, Antonietta ^d   Torzilli, Guido ^a   Di Tommaso, Luca ^f   Giuliante, Felice ^g   Vecchio, Fabio Maria ^g   Salizzoni, Mauro ^h   David, Ezio ^h   Pinna, Antonio Daniele ^d   Guglielmi, Alfredo ^c   Capussotti, Lorenzo ^b  

^a HUMANITAS UNIVERSITY   (Italy)

^b MAURIZIANO HOSPITAL   (Italy)

^c University and Hospital Trust of Verona   (Italy)

^d UNIVERSITY OF BOLOGNA   (Italy)

^e UNIVERSITY HOSPITAL OF VERONA   (Italy)

^f HUMANITAS CLINICAL AND RESEARCH CENTER   (Italy)

^g CATHOLIC UNIVERSITY   (Italy)

^h CITTÀ DELLA SALUTE E DELLA SCIENZA HOSPITAL   (Italy)

Author keywords

Cirrhosis; HCV related HCC; Hepatocellular carcinoma; Liver failure; Liver surgery; Metabolic syndrome; Non alcoholic fatty liver disease; Non alcoholic steatohepatitis; Obesity; Steatosis; Survival

Indexed keywords

ALANINE AMINOTRANSFERASE; ALBUMIN; ASPARTATE AMINOTRANSFERASE; CREATININE; GAMMA GLUTAMYLTRANSFERASE;

ABDOMINAL WALL DEFECT; ADULT; AGE; AGED; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ALBUMIN BLOOD LEVEL; ARTICLE; ASCITES; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BILE LEAKAGE; BLOOD TRANSFUSION; BODY MASS; CANCER PATIENT; CANCER SIZE; CANCER SURGERY; CANCER SURVIVAL; CHILD PUGH SCORE; CHRONIC HEPATITIS; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DIABETES MELLITUS; DIGESTIVE SYSTEM DISEASE ASSESSMENT; DISEASE SEVERITY; DYSLIPIDEMIA; FEMALE; GAMMA GLUTAMYL TRANSFERASE BLOOD LEVEL; GENDER; HEART ARRHYTHMIA; HEART INFARCTION; HEPATITIS B; HUMAN; HYPERTENSION; INTERNATIONAL NORMALIZED RATIO; LENGTH OF STAY; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; LIVER FAILURE; LIVER NODULE; LIVER RESECTION; LUNG DISEASE; MAJOR CLINICAL STUDY; MAJOR SURGERY; MALE; MELD SCORE; METABOLIC SYNDROME X; MORBIDITY; NONALCOHOLIC FATTY LIVER; OVERALL SURVIVAL; PORTAL HYPERTENSION; PORTAL VEIN THROMBOSIS; POSTOPERATIVE COMPLICATION; PREOPERATIVE CARE; PRIORITY JOURNAL; PYREXIA IDIOPATHICA; RECURRENCE FREE SURVIVAL; REOPERATION; RETROSPECTIVE STUDY; SEPSIS; STEATOSIS; SURGICAL MORTALITY; THROMBOCYTE COUNT; TREATMENT OUTCOME; TUMOR INVASION; CARCINOMA, HEPATOCELLULAR; CHRONIC HEPATITIS C; CLINICAL TRIAL; COMPLICATION; FOLLOW UP; LIVER NEOPLASMS; MIDDLE AGED; MULTICENTER STUDY; PROCEDURES; VERY ELDERLY; VIROLOGY;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, HEPATOCELLULAR; FEMALE; FOLLOW-UP STUDIES; HEPATECTOMY; HEPATITIS C, CHRONIC; HUMANS; LIVER NEOPLASMS; MALE; METABOLIC SYNDROME X; MIDDLE AGED; RETROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 84931559917     PISSN: 01688278     EISSN: 16000641     Source Type: Journal    
DOI: 10.1016/j.jhep.2015.01.024     Document Type: Article

References (47)

1. H.B. El-Serag Hepatocellular carcinoma N Engl J Med 365 2011 1118 1127
2. J.A. Davila, R.O. Morgan, Y. Shaib, K.A. McGlynn, and H.B. El-Serag Hepatitis C infection and the increasing incidence of hepatocellular carcinoma: a population-based study Gastroenterology 127 2004 1372 1380
3. V. Ratziu, L. Bonyhay, V. Di Martino, F. Charlotte, L. Cavallaro, and M.H. Sayegh-Tainturier Survival, liver failure, and hepatocellular carcinoma in obesity-related cryptogenic cirrhosis Hepatology 35 2002 1485 1493
4. A.B. Siegel, and A.X. Zhu Metabolic syndrome and hepatocellular carcinoma: two growing epidemics with a potential link Cancer 115 2009 5651 5661
5. L.A. Adams, J.F. Lymp, J. St Suaver, S.O. Sanderson, K.D. Lindor, and A. Feldstein The natural history of nonalcoholic fatty liver disease: a population-based cohort study Gastroenterology 129 2005 113 121
6. B.Q. Starley, C.J. Calcagno, and S.A. Harrison Nonalcoholic fatty liver disease and hepatocellular carcinoma: a weighty connection Hepatology 51 2010 1820 1832
7. H.B. El-Serag, T. Tran, and J.E. Everhart Diabetes increases the risk of chronic liver disease and hepatocellular carcinoma Gastroenterology 126 2004 460 468
8. S.M. Grundy, H.B. Brewer Jr., J.I. Cleeman, S.C. Smith Jr., C. Lenfant American Heart Association National Heart, Lung, and Blood Institute Definition of metabolic syndrome: Report of the National Heart, Lung, and Blood Institute/American Heart Association conference on scientific issues related to definition Circulation 109 2004 433 438
9. T.M. Welzel, B.I. Graubard, S. Zeuzem, H.B. El-Serag, J.A. Davila, and K.A. McGlynn Metabolic syndrome increases the risk of primary liver cancer in the United States: a study in the SEER-Medicare database Hepatology 54 2011 463 471
10. R. Jinjuvadia, S. Patel, and S. Liangpunsakul The association between metabolic syndrome and hepatocellular carcinoma: systemic review and meta-analysis J Clin Gastroenterol 48 2014 172 177
11. J.M. Regimbeau, M. Colombat, P. Mognol, F. Durand, E. Abdalla, and C. Degott Obesity and diabetes as a risk factor for hepatocellular carcinoma Liver Transpl 10 2004 S69 73
12. J.B. Wong, G.M. McQuillan, J.G. McHutchinson, and T. Poynard Estimating future hepatitis C morbidity, mortality, and costs in the United States Am J Public Health 90 2000 562 1569
13. L. Viganò, M.D. Kluger, A. Laurent, C. Tayar, J.C. Merle, and J.Y. Lauzet Liver resection in obese patients: results of a case-control study HPB 13 2011 103 111
14. S. Balzan, G. Nagarajan, O. Farges, C.Z. Galleano, S. Dokmak, and C. Paugam Safety of liver resections in obese and overweight patients World J Surg 34 2010 2960 2968
15. J.K. Saunders, A.S. Rosman, D. Neihaus, T.H. Gouge, and M. Melis Safety of hepatic resections in obese veterans Arch Surg 147 2012 331 337
16. A. Cucchetti, M. Cescon, G. Ercolani, P. Di Gioia, E. Peri, and A.D. Pinna Safety of hepatic resection in overweight and obese patients with cirrhosis Br J Surg 98 2011 1147 1154
17. A.K. Mathur, A.A. Ghaferi, N.H. Osborne, T.M. Pawlik, D.A. Campbell, and M.J. Englesbe Body mass index and adverse perioperative outcomes following hepatic resection J Gastrointest Surg 14 2010 1285 1291
18. T. Utsunomiya, M. Okamoto, T. Kameyama, A. Matsuyama, M. Yamamoto, and M. Fujiwara Impact of obesity on the surgical outcome following repeat hepatic resection in Japanese patients with recurrent hepatocellular carcinoma World J Gastroenterol 14 2008 1553 1558
19. P. Pessaux, M.A. van den Broek, T. Wu, S.W. Olde Damink, T. Piardi, and C.H. Dejong Identification and validation of risk factors for postoperative infectious complications following hepatectomy J Gastrointest Surg 17 2013 1907 1916
20. N.H. Bhayani, O. Hyder, W. Frederick, R.D. Schulick, C.L. Wolgang, and K. Hirose Effect of metabolic syndrome on perioperative outcomes after liver surgery: a National Surgical Quality Improvement Program (NSQIP) analysis Surgery 152 2012 218 226
21. A. Zarzavadjian Le Bian, R. Costi, V. Constantinides, and C. Smadja Metabolic disorders, non-alcoholic fatty liver disease and major liver resection: an underestimated perioperative risk J Gastrointest Surg 16 2012 2247 2255
22. T. Wakai, Y. Shirai, J. Sakata, P.V. Korita, Y. Ajioka, and K. Hatakeyama Surgical outcomes for hepatocellular carcinoma in nonalcoholic fatty liver disease J Gastrointest Surg 15 2011 1450 1458
23. S.K. Reddy, J.L. Steel, H.W. Chen, D.J. DeMateo, J. Cardinal, and J. Behari Outcomes of curative treatment for hepatocellular cancer in nonalcoholic steatohepatitis versus hepatitis C and alcoholic liver disease Hepatology 55 2012 1809 1819
24. A.B. Siegel, E.A. Lim, S. Wang, W. Brubaker, R.D. Rodriguez, and A. Goyal Diabetes, body mass index, and outcomes in hepatocellular carcinoma patients undergoing liver transplantation Transplantation 94 2012 539 543
25. Y. Kawamura, K. Ikeda, Y. Arase, H. Yatsuji, H. Sezaki, and T. Hosaka Diabetes mellitus worsens the recurrence rate after potentially curative therapy in patients with hepatocellular carcinoma associated with nonviral hepatitis J Gastroenterol Hepatol 23 2008 1739 1746
26. A.B. Siegel, S. Wang, J.S. Jacobson, D.L. Hershman, E.A. Lim, and J. Yu Obesity and microvascular invasion in hepatocellular carcinoma Cancer Invest 28 2010 1063 1069
27. F. Cauchy, S. Zalinski, S. Dokmak, D. Fuks, O. Farges, and L. Castera Surgical treatment of hepatocellular carcinoma associated with the metabolic syndrome Br J Surg 100 2013 113 121
28. K.G. Alberti, P. Zimmet, and J. Shaw Metabolic syndrome-a new world-wide definition. A Consensus Statement from the International Diabetes Federation Diabet Med 23 2006 469 480
29. R.N. Pugh, I.M. Murray-Lyon, J.L. Dawson, M.C. Pietroni, and R. Williams Transection of the oesophagus for bleeding oesophageal varices Br J Surg 60 1973 646 649
30. M. Malinchoc, P.S. Kamath, F.D. Gordon, C.J. Peine, J. Rank, and P.C. ter Borg A model to predict poor survival in patients undergoing transjugular intrahepatic portosystemic shunts Hepatology 31 2000 864 871
31. L. Capussotti, A. Ferrero, L. Viganò, A. Muratore, R. Polastri, and H. Bouzari Portal hypertension: contraindication to liver surgery? World J Surg 30 2006 992 999
32. S. Ogata, J. Belghiti, O. Farges, D. Varma, A. Sibert, and V. Vilgrain Sequential arterial and portal vein embolizations before right hepatectomy in patients with cirrhosis and hepatocellular carcinoma Br J Surg 93 2006 1091 1098
33. K. Ishak, A. Baptista, L. Bianchi, F. Callea, J. De Groote, and F. Gudat Histologic grading and staging of chronic hepatitis J Hepatol 22 1995 696 699
34. D.E. Kleiner, E.M. Brunt, M. Van Natta, C. Behling, M.J. Contos, and O.W. Cummings Design and validation of a histological scoring system for nonalcoholic fatty liver disease Hepatology 41 2005 1313 1321
35. D. Dindo, N. Demartines, and P.A. Clavien Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey Ann Surg 240 2004 205 213
36. N.N. Rahbari, O.J. Garden, R. Padbury, M. Brooke-Smith, M. Crawford, and R. Adam Posthepatectomy liver failure: a definition and grading by the International Study Group of Liver Surgery (ISGLS) Surgery 149 2011 713 724
37. V. Paradis, S. Zalinski, E. Chelbi, N. Guedj, F. Degos, and V. Vilgrain Hepatocellular carcinomas in patients with metabolic syndrome often develop without significant liver fibrosis: a pathological analysis Hepatology 49 2009 851 859
38. J. Ertle, A. Dechene, J.P. Sowa, V. Penndorf, K. Herzer, and G. Kaiser Non-alcoholic fatty liver disease progresses to hepatocellular carcinoma in the absence of apparent cirrhosis Int J Cancer 128 2011 2436 2443
39. S.K. Reddy, J.W. Marsh, P.R. Varley, B.K. Mock, K.B. Chopra, and D.A. Geller Underlying steatohepatitis, but not simple hepatic steatosis, increases morbidity after liver resection: a case-control study Hepatology 56 2012 2221 2230
40. V.E. de Meijer, B.T. Kalish, M. Puder, and J.N. Ijzermans Systematic review and meta-analysis of steatosis as a risk factor in major hepatic resection Br J Surg 97 2010 1331 1339
41. R. Veteläinen, A. van Vliet, D.J. Gouma, and T.M. van Gulik Steatosis as a risk factor in liver surgery Ann Surg 245 2007 20 30
42. J.N. Vauthey, T.M. Pawlik, D. Ribero, T.T. Wu, D. Zorzi, and P.M. Hoff Chemotherapy regimen predicts steatohepatitis and an increase in 90-day mortality after surgery for hepatic colorectal metastases J Clin Oncol 24 2006 2065 2072
43. H. Imamura, Y. Seyama, N. Kokudo, A. Maema, Y. Sugawara, and K. Sano One thousand fifty-six hepatectomies without mortality in 8 years Arch Surg 138 2003 1198 1206
44. See comment in PubMed Commons below T. Kamiyama, K. Nakanishi, H. Yokoo, H. Kamachi, M. Tahara, and K. Yamashita Perioperative management of hepatic resection toward zero mortality and morbidity: analysis of 793 consecutive cases in a single institution J Am Coll Surg 211 2010 443 449
45. L. Viganò, N. Russolillo, A. Ferrero, S. Langella, E. Sperti, and L. Capussotti Evolution of long-term outcome of liver resection for colorectal metastases: analysis of actual 5-year survival rates over two decades Ann Surg Oncol 19 2012 2035 2044
46. E. Bugianesi, N. Leone, E. Vanni, G. Marchesini, F. Brunello, and P. Carucci Expanding the natural history of nonalcoholic steatohepatitis: from cryptogenic cirrhosis to hepatocellular carcinoma Gastroenterology 123 2002 134 140
47. J.M. Page, and S.A. Harrison NASH and HCC Clin Liver Dis 13 2009 631 647